Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -174,206 | -108,494 | -46,833 | -122,526 | -86,047 |
| Depreciation Amortization | -11,907 | -8,972 | -4,923 | -17,473 | -11,721 |
| Accounts payable and accrued liabilities | 9,772 | 966 | 686 | 3,307 | 3,730 |
| Other Working Capital | 5,792 | -3,720 | -6,803 | 2,964 | 3,498 |
| Other Operating Activity | 12,766 | 13,433 | 5,644 | 17,092 | 10,371 |
| Operating Cash Flow | $-157,783 | $-106,787 | $-52,229 | $-116,636 | $-80,169 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,616 | 83,521 | 34,347 | -357,619 | -390,867 |
| PPE Investments | -2,118 | -546 | -314 | -1,290 | -1,274 |
| Other Investing Activity | 5,158 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $33,656 | $82,975 | $34,033 | $-358,909 | $-392,141 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 58,917 | 1,482 | 965 | 517,059 | 516,444 |
| Other Financing Activity | -1,388 | -156 | -156 | -1,796 | -1,796 |
| Financing Cash Flow | $57,529 | $1,326 | $809 | $515,263 | $514,648 |
| Beginning Cash Position | 169,510 | 169,510 | 169,510 | 129,792 | 129,792 |
| End Cash Position | 102,912 | 147,024 | 152,123 | 169,510 | 172,130 |
| Net Cash Flow | $-66,598 | $-22,486 | $-17,387 | $39,718 | $42,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -157,783 | -106,787 | -52,229 | -116,636 | -80,169 |
| Capital Expenditure | -2,118 | -546 | -314 | -1,290 | -1,274 |
| Free Cash Flow | -159,901 | -107,333 | -52,543 | -117,926 | -81,443 |